ArticleJournal for immunotherapy of cancer2024

Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.

Sofie Kirial Mørk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.